MicroRNAs in vascular tissue engineering and post-ischemic neovascularization

Advanced Drug Delivery Reviews

Volumn 88, Issue , 2015, Pages 78-91

  Caputo, Massimo ^a,b   Saif, Jaimy ^a   Rajakaruna, Cha ^a   Brooks, Marcus ^c   Angelini, Gianni D ^a,d   Emanueli, Costanza ^a,d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Aneurysms; Congenital acquired heart disease; Ischemic disease; MicroRNAs; Therapeutic angiogenesis; Vascular tissue engineering

Indexed keywords

CELL ENGINEERING; PEDIATRICS; RNA; TISSUE;

ANEURYSMS; HEART DISEASE; MICRORNAS; THERAPEUTIC ANGIOGENESIS; VASCULAR TISSUE ENGINEERING;

TISSUE ENGINEERING;

MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 10; MICRORNA 101; MICRORNA 132; MICRORNA 143; MICRORNA 145; MICRORNA 150; MICRORNA 155; MICRORNA 17 5P; MICRORNA 17 92; MICRORNA 181A; MICRORNA 181B; MICRORNA 18A; MICRORNA 19A; MICRORNA 200C; MICRORNA 21; MICRORNA 217; MICRORNA 221; MICRORNA 222; MICRORNA 24; MICRORNA 29A; MICRORNA 31; MICRORNA 34; MICRORNA 347; MICRORNA 34A; MICRORNA 503; MICRORNA 99B; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ABDOMINAL AORTA ANEURYSM; ANGIOGENESIS; ARTERY GRAFT; BLOOD VESSEL; CELL DIFFERENTIATION; CONGENITAL HEART MALFORMATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GENE TARGETING; HEART GRAFT; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; POST-ISCHEMIA ANGIOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA SYNTHESIS; STEM CELL; TISSUE ENGINEERING; TISSUE SCAFFOLD; VASCULAR PROGENITOR CELL; VASCULAR SMOOTH MUSCLE CELL; VASCULAR TISSUE ENGINEERING; VEIN GRAFT; ANEURYSM; ISCHEMIA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PERICYTE; PROCEDURES; VASCULAR SMOOTH MUSCLE;

ANEURYSM; BLOOD VESSELS; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; HEART DEFECTS, CONGENITAL; HUMANS; ISCHEMIA; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; STEM CELLS; TISSUE ENGINEERING;

EID: 84937525923     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2015.05.003     Document Type: Review

References (162)

1. Alberts B.J.A., Lewis J., et al. Molecular Biology of the Cell 2002, 4.
2. Wanjare M., Kusuma S., Gerecht S. Perivascular cells in blood vessel regeneration. Biotechnol. J. 2013, 8:434-447.
3. Krumhaar D., Schmidt H.-D., Schulz U. Quantitative evaluation of retrograde arterial flow in chronic experimental arteriovenous fistulas. Basic Res. Cardiol. 1975, 70:29-45.
4. Masuda H., Asahara T. Post-natal endothelial progenitor cells for neovascularization in tissue regeneration. Cardiovasc. Res. 2003, 58:390-398.
5. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., Magner M., Isner J.M., Asahara T. Ischemia-and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 1999, 5:434-438.
6. Raval Z., Losordo D.W. Cell therapy of peripheral arterial disease from experimental findings to clinical trials. Circ. Res. 2013, 112:1288-1302.
7. Beohar N., Rapp J., Pandya S., Losordo D.W. Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease. J. Am. Coll. Cardiol. 2010, 56:1287-1297.
8. Gupta R., Tongers J., Losordo D.W. Human studies of angiogenic gene therapy. Circ. Res. 2009, 105:724-736.
9. Rissanen T.T., Ylä-Herttuala S. Current status of cardiovascular gene therapy. Mol. Ther. 2007, 15:1233-1247.
10. Yang W.J., Yang D.D., Na S., Sandusky G.E., Zhang Q., Zhao G. Dicer is required for embryonic angiogenesis during mouse development. J. Biol. Chem. 2005, 280:9330-9335.
11. Kane N.M., Howard L., Descamps B., Meloni M., McClure J., Lu R., McCahill A., Breen C., Mackenzie R.M., Delles C., Mountford J.C., Milligan G., Emanueli C., Baker A.H. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells 2012, 30:643-654.
12. van der Bom T., Zomer A.C., Zwinderman A.H., Meijboom F.J., Bouma B.J., Mulder B.J. The changing epidemiology of congenital heart disease. Nat. Rev. Cardiol. 2010, 8:50-60.
13. Ohye R.G., Bove E.L. Advances in congenital heart surgery. Curr. Opin. Pediatr. 2001, 13:473-481.
14. Mascio C.E., Pasquali S.K., Jacobs J.P., Jacobs M.L., Austin E.H. Outcomes in adult congenital heart surgery: analysis of the Society of Thoracic Surgeons Database. J. Thorac. Cardiovasc. Surg. 2011, 142:1090-1097.
15. Thompson S., Ashton H., Gao L., Scott R. Screening men for abdominal aortic aneurysm: 10year mortality and cost effectiveness results from the randomised Multicentre Aneurysm Screening Study. BMJ 2009, 338.
16. Hiratzka L.F., Bakris G.L., Beckman J.A., Bersin R.M., Carr V.F., Casey D.E., Eagle K.A., Hermann L.K., Isselbacher E.M., Kazerooni E.A., Kouchoukos N.T., Lytle B.W., Milewicz D.M., Reich D.L., Sen S., Shinn J.A., Svensson L.G., Williams D.M. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010, 121:e266-e369.
17. Ramanath V.S., Oh J.K., Sundt T.M., Eagle K.A. Acute aortic syndromes and thoracic aortic aneurysm. Mayo Clinic Proceedings 2009, 84:465-481.
18. Kuzmik G.A., Sang A.X., Elefteriades J.A. Natural history of thoracic aortic aneurysms. J. Vasc. Surg. 2012, 56:565-571.
19. Majesky M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1248-1258.
20. Davis F.M., Rateri D.L., Daugherty A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 2014, 305648. (heartjnl-2014).
21. Spinetti G., Kraenkel N., Emanueli C., Madeddu P. Diabetes and vessel wall remodeling: from mechanistic insights to regenerative therapies. Cardiovasc. Res. 2008, 78(2):265-273.
22. Laube H.R., Duwe J., Rutsch W., Konertz W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J. Thorac. Cardiovasc. Surg. 2000, 120:134-141.
23. L'Heureux N., Dusserre N., Marini A., Garrido S., de la Fuente L., McAllister T. Technology insight: the evolution of tissue-engineered vascular grafts-from research to clinical practice. Nat. Clin. Pract. Cardiovasc. Med. 2007, 4:389-395.
24. Kane N.M., Thrasher A.J., Angelini G.D., Emanueli C. Concise review: MicroRNAs as modulators of stem cells and angiogenesis. Stem Cells 2014, 32:1059-1066.
25. Wang B., Borazjani A., Tahai M., Curry A.L., Simionescu D.T., Guan J., To F., Elder S.H., Liao J. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells. J. Biomed. Mater. Res. A 2010, 94:1100-1110.
26. Grauss R.W., Hazekamp M.G., Oppenhuizen F., van Munsteren C.J., Gittenberger-de Groot A.C., DeRuiter M.C. Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods. Eur. J. Cardiothorac. Surg. 2005, 27:566-571.
27. Schenke-Layland K., Vasilevski O., Opitz F., Konig K., Riemann I., Halbhuber K.J., Wahlers T., Stock U.A. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol. 2003, 143:201-208.
28. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials 2006, 27:3675-3683.
29. Clarke D.R., Lust R.M., Sun Y.S., Black K.S., Ollerenshaw J.D. Transformation of nonvascular acellular tissue matrices into durable vascular conduits. Ann. Thorac. Surg. 2001, 71:S433-S436.
30. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., Rieder E., Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur. J. Cardiothorac. Surg. 2003, 23:1002-1006. (discussion 1006).
31. Bader A., Steinhoff G., Strobl K., Schilling T., Brandes G., Mertsching H., Tsikas D., Froelich J., Haverich A. Engineering of human vascular aortic tissue based on a xenogeneic starter matrix. Transplantation 2000, 70:7-14.
32. Tamura N., Nakamura T., Terai H., Iwakura A., Nomura S., Shimizu Y., Komeda M. A new acellular vascular prosthesis as a scaffold for host tissue regeneration. Int. J. Artif. Organs 2003, 26:783-792.
33. Kaushal S., Amiel G.E., Guleserian K.J., Shapira O.M., Perry T., Sutherland F.W., Rabkin E., Moran A.M., Schoen F.J., Atala A., Soker S., Bischoff J., Mayer J.E. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat. Med. 2001, 7:1035-1040.
34. Kalfa D., Bacha E. New technologies for surgery of the congenital cardiac defect. Rambam Maimonides Med. J. 2013, 4.
35. Witt R.G., Raff G., Van Gundy J., Rodgers-Ohlau M., Si M.-S. Short-term experience of porcine small intestinal submucosa patches in paediatric cardiovascular surgery. Eur. J. Cardiothorac. Surg. 2013, 44:72-76.
36. Rivron N., Liu J., Rouwkema J., Boer dJ, Blitterswijk vC Engineering vascularised tissues in vitro. Eur. Cell. Mater. 2008, 15:27-40.
37. Beamish J.A., He P., Kottke-Marchant K., Marchant R.E. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng. B Rev. 2010, 16:467-491.
38. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
39. Niklason L., Gao J., Abbott W., Hirschi K., Houser S., Marini R., Langer R. Functional arteries grown in vitro. Science 1999, 284:489-493.
40. Olausson M., Patil P.B., Kuna V.K., Chougule P., Hernandez N., Methe K., Kullberg-Lindh C., Borg H., Ejnell H., Sumitran-Holgersson S. Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study. Lancet 2012, 380:230-237.
41. L'Heureux N., Germain L., Labbé R., Auger F.A. In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. J. Vasc. Surg. 1993, 17:499-509.
42. Shin'oka T., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N. Engl. J. Med. 2001, 344:532-533.
43. Park K.M., Gerecht S. Harnessing developmental processes for vascular engineering and regeneration. Development 2014, 141:2760-2769.
44. Würdinger T., Tannous B.A., Saydam O., Skog J., Grau S., Soutschek J., Weissleder R., Breakefield X.O., Krichevsky A.M. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell 2008, 14:382-393.
45. Pan Y., Liang H., Liu H., Li D., Chen X., Li L., Zhang C.-Y., Zen K. Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor. J. Immunol. 2014, 192:437-446.
46. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
47. Kozomara A., Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 2011, 39:D152-D157.
48. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
49. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
50. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 2005, 6:376-385.
51. Kim Y.J., Maizel A., Chen X. Traffic into silence: endomembranes and post-transcriptional RNA silencing. EMBO J. 2014, 33:968-980.
52. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
53. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
54. Fukaya T., Tomari Y. MicroRNAs mediate gene silencing via multiple different pathways in drosophila. Mol. Cell 2012, 48:825-836.
55. Djuranovic S., Nahvi A., Green R. miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science 2012, 336:237-240.
56. Bazzini A.A., Lee M.T., Giraldez A.J. Ribosome profiling shows that miR-430 reduces translation before causing mRNA decay in zebrafish. Science 2012, 336:233-237.
57. Liu N., Olson E.N. MicroRNA regulatory networks in cardiovascular development. Dev. Cell 2010, 18:510-525.
58. Epstein S.E., Kornowski R., Fuchs S., Dvorak H.F. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 2001, 104:115-119.
59. Doebele C., Bonauer A., Fischer A., Scholz A., Reiss Y., Urbich C., Hofmann W.K., Zeiher A.M., Dimmeler S. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950.
60. Bonauer A., Carmona G., Iwasaki M., Mione M., Koyanagi M., Fischer A., Burchfield J., Fox H., Doebele C., Ohtani K., Chavakis E., Potente M., Tjwa M., Urbich C., Zeiher A.M., Dimmeler S. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
61. Loyer X., Potteaux S., Vion A.C., Guerin C.L., Boulkroun S., Rautou P.E., Ramkhelawon B., Esposito B., Dalloz M., Paul J.L., Julia P.L., Maccario J., Boulanger C.M., Mallat Z., Tedgui A. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ. Res. 2013, 114(3):434-443.
62. Poliseno L., Tuccoli A., Mariani L., Evangelista M., Citti L., Woods K., Mercatanti A., Hammond S., Rainaldi G. MicroRNAs modulate the angiogenic properties of HUVECs. Blood 2006, 108:3068-3071.
63. Anand S., Majeti B.K., Acevedo L.M., Murphy E.A., Mukthavaram R., Scheppke L., Huang M., Shields D.J., Lindquist J.N., Lapinski P.E. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis. Nat. Med. 2010, 16:909-914.
64. Chen Y., Gorski D.H. Regulation of angiogenesis through a microRNA (miR-130a) that down-regulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008, 111:1217-1226.
65. Fasanaro P., D'Alessandra Y., Di Stefano V., Melchionna R., Romani S., Pompilio G., Capogrossi M.C., Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J. Biol. Chem. 2008, 283:15878-15883.
66. Wang S., Olson E.N. AngiomiRs-key regulators of angiogenesis. Curr. Opin. Genet. Dev. 2009, 19:205-211.
67. Bonauer A., Boon R., Dimmeler S. Vascular micrornas. Curr. Drug Targets 2010, 11:943-949.
68. Caporali A., Emanueli C. MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc. Med. 2011, 21:162-166.
69. Kumar S., Kim C.W., Simmons R.D., Jo H. Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis mechanosensitive athero-miRs. Arterioscler. Thromb. Vasc. Biol. 2014, 34:2206-2216.
70. Marin T., Gongol B., Chen Z., Woo B., Subramaniam S., Chien S., Shyy J.Y.-J. Mechanosensitive microRNAs-role in endothelial responses to shear stress and redox state. Free Radic. Biol. Med. 2013, 64:61-68.
71. Walles T., Görler H., Puschmann C., Mertsching H. Functional neointima characterization of vascular prostheses in human. Ann. Thorac. Surg. 2004, 77:864-868.
72. Yang J., Nagavarapu U., Relloma K., Sjaastad M.D., Moss W.C., Passaniti A., Herron G.S. Telomerized human microvasculature is functional in vivo. Nat. Biotechnol. 2001, 19:219-224.
73. Menghini R., Casagrande V., Cardellini M., Martelli E., Terrinoni A., Amati F., Vasa-Nicotera M., Ippoliti A., Novelli G., Melino G., Lauro R., Federici M. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.
74. Emanueli C., Thum T. miRNAGE-34 induces cardiac damAGE. Cell Res. 2013, 23:866-867.
75. Ito T., Yagi S., Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem. Biophys. Res. Commun. 2010, 398:735-740.
76. Bernardo B.C., Gao X.-M., Winbanks C.E., Boey E.J., Tham Y.K., Kiriazis H., Gregorevic P., Obad S., Kauppinen S., Du X.-J. Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proceedings of the National Academy of Sciences 2012, 109:17615-17620.
77. Boon R.A., Iekushi K., Lechner S., Seeger T., Fischer A., Heydt S., Kaluza D., Tréguer K., Carmona G., Bonauer A. MicroRNA-34a regulates cardiac ageing and function. Nature 2013, 495:107-110.
78. Katare R., Riu F., Mitchell K., Gubernator M., Campagnolo P., Cui Y., Fortunato O., Avolio E., Cesselli D., Beltrami A.P., Angelini G., Emanueli C., Madeddu P. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ. Res. 2011, 109:894-906.
79. Chan S.Y., Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010, 9:1072-1083.
80. Meloni M., Marchetti M., Garner K., Littlejohns B., Sala-Newby G., Xenophontos N., Floris I., Suleiman M.S., Madeddu P., Caporali A., Emanueli C. Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol. Ther. 2013, 21:1390-1402.
81. Hullinger T.G., Montgomery R.L., Seto A.G., Dickinson B.A., Semus H.M., Lynch J.M., Dalby C.M., Robinson K., Stack C., Latimer P.A., Hare J.M., Olson E.N., van Rooij E. Inhibition of miR-15 protects against cardiac ischemic injury. Circ. Res. 2012, 110:71-81.
82. Fiedler J., Jazbutyte V., Kirchmaier B.C., Gupta S.K., Lorenzen J., Hartmann D., Galuppo P., Kneitz S., Pena J.T., Sohn-Lee C., Loyer X., Soutschek J., Brand T., Tuschl T., Heineke J., Martin U., Schulte-Merker S., Ertl G., Engelhardt S., Bauersachs J., Thum T. MicroRNA-24 regulates vascularity after myocardial infarction. Circulation 2011, 124:720-730.
83. Spinetti G., Fortunato O., Caporali A., Shantikumar S., Marchetti M., Meloni M., Descamps B., Floris I., Sangalli E., Vono R., Faglia E., Specchia C., Pintus G., Madeddu P., Emanueli C. MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia. Circ. Res. 2013, 112:335-346.
84. Suárez Y., Fernández-Hernando C., Pober J.S., Sessa W.C. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ. Res. 2007, 100:1164-1173.
85. Ghosh G., Subramanian I.V., Adhikari N., Zhang X., Joshi H.P., Basi D., Chandrashekhar Y.S., Hall J.L., Roy S., Zeng Y., Ramakrishnan S. Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-alpha isoforms and promotes angiogenesis. J. Clin. Invest. 2010, 120:4141-4154.
86. Magenta A., Cencioni C., Fasanaro P., Zaccagnini G., Greco S., Sarra-Ferraris G., Antonini A., Martelli F., Capogrossi M. miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ. 2011, 18:1628-1639.
87. Menghini R., Casagrande V., Cardellini M., Martelli E., Terrinoni A., Amati F., Vasa-Nicotera M., Ippoliti A., Novelli G., Melino G. MicroRNA 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009, 120:1524-1532.
88. Zhao T., Li J., Chen A.F. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am. J. Physiol. Endocrinol. Metab. 2010, 299:E110-E116.
89. Shantikumar S., Caporali A., Emanueli C. Role of miRNA in diabetes and its cardiovascular complications. Cardiovasc. Res. 2011, cvr300.
90. Caporali A., Meloni M., Völlenkle C., Bonci D., Sala-Newby G.B., Addis R., Spinetti G., Losa S., Masson R., Baker A.H. Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia. Circulation 2011, 123:282-291.
91. Floris I., Descamps B., Vardeu A., Mitić T., Posadino A.M., Shantikumar S., Sala-Newby G., Capobianco G., Mangialardi G., Howard L. Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving MicroRNA-101 and histone methyltransferase enhancer of zester homolog-2. Arterioscler. Thromb. Vasc. Biol. 2015, 114:304730.
92. Dobaczewski M., Akrivakis S., Nasser K., Michael L.H., Entman M.L., Frangogiannis N.G. Vascular mural cells in healing canine myocardial infarcts. J. Histochem. Cytochem. 2004, 52:1019-1029.
93. Birbrair A., Zhang T., Wang Z.-M., Messi M.L., Mintz A., Delbono O. Pericytes at the intersection between tissue regeneration and pathology. Clin. Sci. 2015, 128:81-93.
94. Larsson E., Fredlund Fuchs P., Heldin J., Barkefors I., Bondjers C., Genové G., Arrondel C., Gerwins P., Kurschat C., Schermer B. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med. 2009, 1. (108-108).
95. Truettner J.S., Katyshev V., Esen-Bilgin N., Dietrich W.D., Dore-Duffy P. Hypoxia alters MicroRNA expression in rat cortical pericytes. MicroRNA. 2013, 2:32.
96. He W., Nieponice A., Soletti L., Hong Y., Gharaibeh B., Crisan M., Usas A., Peault B., Huard J., Wagner W.R. Pericyte-based human tissue engineered vascular grafts. Biomaterials 2010, 31:8235-8244.
97. Invernici G., Emanueli C., Madeddu P., Cristini S., Gadau S., Benetti A., Ciusani E., Stassi G., Siragusa M., Nicosia R. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am. J. Pathol. 2007, 170:1879-1892.
98. Ren G., Michael L.H., Entman M.L., Frangogiannis N.G. Morphological characteristics of the microvasculature in healing myocardial infarcts. J. Histochem. Cytochem. 2002, 50:71-79.
99. Beltramo E., Porta M. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr. Med. Chem. 2013, 20:3218-3225.
100. Hayden M.R., Yang Y., Habibi J., Bagree S.V., Sowers J.R. Pericytopathy: oxidative stress and impaired cellular longevity in the pancreas and skeletal muscle in metabolic syndrome and type 2 diabetes. Oxidative Med. Cell. Longev. 2010, 3:290-303.
101. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801.
102. Lacolley P., Regnault V., Nicoletti A., Li Z., Michel J.-B. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 2012, 95:194-204.
103. Silber S., Colombo A., Banning A.P., Hauptmann K., Drzewiecki J., Grube E., Dudek D., Baim D.S. Final 5-year results of the TAXUS II trial A randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions. Circulation 2009, 120:1498-1504.
104. Xin M., Small E.M., Sutherland L.B., Qi X., McAnally J., Plato C.F., Richardson J.A., Bassel-Duby R., Olson E.N. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009, 23:2166-2178.
105. Boettger T., Beetz N., Kostin S., Schneider J., Krüger M., Hein L., Braun T. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J. Clin. Invest. 2009, 119:2634-2647.
106. Cordes K.R., Sheehy N.T., White M.P., Berry E.C., Morton S.U., Muth A.N., Lee T.-H., Miano J.M., Ivey K.N., Srivastava D. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
107. Elia L., Quintavalle M., Zhang J., Contu R., Cossu L., Latronico M.V., Peterson K.L., Indolfi C., Catalucci D., Chen J. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ. 2009, 16:1590-1598.
108. Fichtlscherer S., De Rosa S., Fox H., Schwietz T., Fischer A., Liebetrau C., Weber M., Hamm C.W., Röxe T., Müller-Ardogan M. Circulating microRNAs in patients with coronary artery disease. Circ. Res. 2010, 107:677-684.
109. Hergenreider E., Heydt S., Tréguer K., Boettger T., Horrevoets A.J., Zeiher A.M., Scheffer M.P., Frangakis A.S., Yin X., Mayr M. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat. Cell Biol. 2012, 14:249-256.
110. Liu X., Cheng Y., Zhang S., Lin Y., Yang J., Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ. Res. 2009, 104:476-487.
111. Liu X., Cheng Y., Yang J., Xu L., Zhang C. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J. Mol. Cell. Cardiol. 2012, 52:245-255.
112. Chan M.C., Hilyard A.C., Wu C., Davis B.N., Hill N.S., Lal A., Lieberman J., Lagna G., Hata A. Molecular basis for antagonism between PDGF and the TGFβ family of signalling pathways by control of miR-24 expression. EMBO J. 2010, 29:559-573.
113. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J. Biol. Chem. 2009, 284:3728-3738.
114. Ji R., Cheng Y., Yue J., Yang J., Liu X., Chen H., Dean D.B., Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ. Res. 2007, 100:1579-1588.
115. Zhang P., Huang A., Ferruzzi J., Mecham R.P., Starcher B.C., Tellides G., Humphrey J.D., Giordano F.J., Niklason L.E., Sessa W.C. Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels-brief report. Arterioscler. Thromb. Vasc. Biol. 2012, 32:756-759.
116. Badi I., Burba I., Ruggeri C., Zeni F., Bertolotti M., Scopece A., Pompilio G., Raucci A. MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors. J. Gerontol. A: Biol. Med. Sci. 2014, glu180.
117. Dahl S.L., Koh J., Prabhakar V., Niklason L.E. Decellularized native and engineered arterial scaffolds for transplantation. Cell Transplant. 2003, 12:659-666.
118. Johnson D., Robson P., Hew Y., Keeley F. Decreased elastin synthesis in normal development and in long-term aortic organ and cell cultures is related to rapid and selective destabilization of mRNA for elastin. Circ. Res. 1995, 77:1107-1113.
119. Kane N.M., Howard L., Descamps B., Meloni M., McClure J., Lu R., McCahill A., Breen C., Mackenzie R.M., Delles C. Role of microRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells 2012, 30:643-654.
120. Kane N.M., Meloni M., Spencer H.L., Craig M.A., Strehl R., Milligan G., Houslay M.D., Mountford J.C., Emanueli C., Baker A.H. Derivation of endothelial cells from human embryonic stem cells by directed differentiation analysis of microRNA and angiogenesis in vitro and in vivo. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1389-1397.
121. Chen T., Bai H., Shao Y., Arzigian M., Janzen V., Attar E., Xie Y., Scadden D.T., Wang Z.Z. Stromal cell-derived factor-1/CXCR4 signaling modifies the capillary-like organization of human embryonic stem cell-derived endothelium in vitro. Stem Cells 2007, 25:392-401.
122. Luo Z., Wen G., Wang G., Pu X., Ye S., Xu Q., Wang W., Xiao Q. MicroRNA-200C and -150 play an important role in endothelial cell differentiation and vasculogenesis by targeting transcription repressor ZEB1. Stem Cells 2013, 31:1749-1762.
123. Fish J.E., Santoro M.M., Morton S.U., Yu S., Yeh R.-F., Wythe J.D., Ivey K.N., Bruneau B.G., Stainier D.Y., Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev. Cell 2008, 15:272-284.
124. Treguer K., Heinrich E.-M., Ohtani K., Bonauer A., Dimmeler S. Role of the microRNA-17-92 cluster in the endothelial differentiation of stem cells. J. Vasc. Res. 2011, 49:447-460.
125. Dar A., Domev H., Ben-Yosef O., Tzukerman M., Zeevi-Levin N., Novak A., Germanguz I., Amit M., Itskovitz-Eldor J. Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation 2012, 125:87-99.
126. Yamaguchi S., Yamahara K., Homma K., Suzuki S., Fujii S., Morizane R., Monkawa T., Matsuzaki Y., Kangawa K., Itoh H. The role of microRNA-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis 2011, 219:468-474.
127. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
128. Xie C., Huang H., Sun X., Guo Y., Hamblin M., Ritchie R.P., Garcia-Barrio M.T., Zhang J., Chen Y.E. MicroRNA-1 regulates smooth muscle cell differentiation by repressing Kruppel-like factor 4. Stem Cells Dev. 2010, 20:205-210.
129. van Mil A., Vrijsen K.R., Goumans M.-J., Metz C.H., Doevendans P.A., Sluijter J.P. microRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells. J. Mol. Med. 2013, 91:1001-1012.
130. Huang H., Xie C., Sun X., Ritchie R.P., Zhang J., Chen Y.E. miR-10a contributes to retinoid acid-induced smooth muscle cell differentiation. J. Biol. Chem. 2010, 285:9383-9389.
131. Mariner P.D., Johannesen E., Anseth K.S. Manipulation of miRNA activity accelerates osteogenic differentiation of hMSCs in engineered 3D scaffolds. J. Tissue Eng. Regen. Med. 2012, 6:314-324.
132. Sahoo S., Klychko E., Thorne T., Misener S., Schultz K.M., Millay M., Ito A., Liu T., Kamide C., Agrawal H. Exosomes from human CD34+ stem cells mediate their proangiogenic paracrine activity. Circ. Res. 2011, 109:724-728.
133. Tano N., Kim H.W., Ashraf M. microRNA-150 regulates mobilization and migration of bone marrow-derived mononuclear cells by targeting Cxcr4. PLoS One 2011, 6:e23114.
134. Li J., Zhang Y., Liu Y., Dai X., Li W., Cai X., Yin Y., Wang Q., Xue Y., Wang C. Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis. J. Biol. Chem. 2013, 288:23586-23596.
135. Misso G., Di Martino M.T., De Rosa G., Farooqi A.A., Lombardi A., Campani V., Zarone M.R., Gullà A., Tagliaferri P., Tassone P. Mir-34: a new weapon against cancer?. Mol. Ther.-Nucleic Acids 2014, 3:e194.
136. Nelson C.E., Gupta M.K., Adolph E.J., Shannon J.M., Guelcher S.A., Duvall C.L. Sustained local delivery of siRNA from an injectable scaffold. Biomaterials 2012, 33:1154-1161.
137. Devalliere J., Chang W.G., Andrejecsk J.W., Abrahimi P., Cheng C.J., Jane-wit D., Saltzman W.M., Pober J.S. Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation. FASEB J. 2014, 28:908-922.
138. Wagner J., Riwanto M., Besler C., Knau A., Fichtlscherer S., Roxe T., Zeiher A.M., Landmesser U., Dimmeler S. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler. Thromb. Vasc. Biol. 2013, 33:1392-1400.
139. Boon R.A., Vickers K.C. Intercellular transport of microRNAs. Arterioscler. Thromb. Vasc. Biol. 2013, 33:186-192.
140. Lai R.C., Arslan F., Lee M.M., Sze N.S., Choo A., Chen T.S., Salto-Tellez M., Timmers L., Lee C.N., El Oakley R.M., Pasterkamp G., de Kleijn D.P., Lim S.K. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010, 4:214-222.
141. Sahoo S., Losordo D.W. Exosomes and cardiac repair after myocardial infarction. Circ. Res. 2014, 114:333-344.
142. Weber J.A., Baxter D.H., Zhang S., Huang D.Y., Huang K.H., Lee M.J., Galas D.J., Wang K. The microRNA spectrum in 12 body fluids. Clin. Chem. 2010, 56:1733-1741.
143. Valadi H., Ekstrom K., Bossios A., Sjostrand M., Lee J.J., Lotvall J.O. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 2007, 9:654-659.
144. Lopatina T., Bruno S., Tetta C., Kalinina N., Porta M., Camussi G. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal 2014, 12:26.
145. Zhang H.-C., Liu X.-B., Huang S., Bi X.-Y., Wang H.-X., Xie L.-X., Wang Y.-Q., Cao X.-F., Lv J., Xiao F.-J. Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev. 2012, 21:3289-3297.
146. Gould S.J., Raposo G. As we wait: coping with an imperfect nomenclature for extracellular vesicles. J. Extracellular Vesicles. 2013, 2.
147. Müller F.-J., Laurent L.C., Kostka D., Ulitsky I., Williams R., Lu C., Park I.-H., Rao M.S., Shamir R., Schwartz P.H. Regulatory networks define phenotypic classes of human stem cell lines. Nature 2008, 455:401-405.
148. Mukherji S., Ebert M.S., Zheng G.X., Tsang J.S., Sharp P.A., van Oudenaarden A. MicroRNAs can generate thresholds in target gene expression. Nat. Genet. 2011, 43:854-859.
149. Khan A.A., Betel D., Miller M.L., Sander C., Leslie C.S., Marks D.S. Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs. Nat. Biotechnol. 2009, 27:549-555.
150. Roy S., Khanna S., Hussain S.-R.A., Biswas S., Azad A., Rink C., Gnyawali S., Shilo S., Nuovo G.J., Sen C.K. MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. Cardiovasc. Res. 2009, 82(1):21-29.
151. Zilla P., Deutsch M., Meinhart J., Puschmann R., Eberl T., Minar E., Dudczak R., Lugmaier H., Schmidt P., Noszian I. Clinical in vitro endothelialization of femoropopliteal bypass grafts: an actuarial follow-up over three years. J. Vasc. Surg. 1994, 19:540-548.
152. Shinoka T., Shum-Tim D., Ma P.X., Tanel R.E., Isogai N., Langer R., Vacanti J.P., Mayer J.E. Creation of viable pulmonary artery autografts through tissue engineering. J. Thorac. Cardiovasc. Surg. 1998, 115:536-546.
153. Doebele C., Bonauer A., Fischer A., Scholz A., Reiss Y., Urbich C., Hofmann W.-K., Zeiher A.M., Dimmeler S. Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 2010, 115:4944-4950.
154. Qin X., Wang X., Wang Y., Tang Z., Cui Q., Xi J., Li Y.S., Chien S., Wang N. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3240-3244.
155. Weber M., Kim S., Patterson N., Rooney K., Searles C.D. MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1192-H1203.
156. Fang Y., Davies P.F. Site-specific microRNA-92a regulation of Krüppel-like factors 4 and 2 in atherosusceptible endothelium. Arterioscler. Thromb. Vasc. Biol. 2012, 32:979-987.
157. Ni C.W., Qiu H., Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1762-H1769.
158. Schober A., Nazari-Jahantigh M., Wei Y., Bidzhekov K., Gremse F., Grommes J., Megens R.T., Heyll K., Noels H., Hristov M. MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1. Nat. Med. 2014, 20:368-376.
159. Fang Y., Shi C., Manduchi E., Civelek M., Davies P.F. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proceedings of the National Academy of Sciences 2010, 107:13450-13455.
160. Kim C.W., Kumar S., Son D.J., Jang I.-H., Griendling K.K., Jo H. Prevention of abdominal aortic aneurysm by anti-microRNA-712 or anti-microRNA-205 in angiotensin II-infused mice. Arterioscler. Thromb. Vasc. Biol. 2014, 34:1412-1421.
161. Nicoli S., Standley C., Walker P., Hurlstone A., Fogarty K.E., Lawson N.D. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature 2010, 464:1196-1200.
162. Suárez Y., Fernández-Hernando C., Yu J., Gerber S.A., Harrison K.D., Pober J.S., Iruela-Arispe M.L., Merkenschlager M., Sessa W.C. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proceedings of the National Academy of Sciences 2008, 105:14082-14087.